Radiotherapy of basal cell carcinoma of the face and head: Importance of low dose per fraction on long-term outcome

2006 ◽  
Vol 4 (2) ◽  
pp. 124-130 ◽  
Author(s):  
Thomas Olschewski ◽  
Katharina Bajor ◽  
Birgit Lang ◽  
Eugen Lang ◽  
Michael H. Seegenschmiedt
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Low Dose ◽  
Term Outcome ◽  
Long Term Outcome ◽  
The Face ◽  
Dose Per Fraction

Diagnosis and Treatment of Tracheal Basal Cell Carcinoma in a Maine Coon and Long-Term Outcome

2012 ◽  
Vol 48 (4) ◽  
pp. 273-277 ◽  
Author(s):  
Michael L. Green ◽  
Julie Smith ◽  
Linda Fineman ◽  
David Proulx
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Surgical Excision ◽  
Definitive Treatment ◽  
Osseous Metaplasia ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Resection And Anastomosis

A 6 yr old castrated male Maine coon presented with a 2 wk history of progressive dyspnea. Thoracic radiographs revealed a 2 cm diameter intratracheal mass at the level of the fourth rib. The tracheal mass was marginally excised via a combination of resection and anastomosis. Infiltrative basal cell carcinoma (BCC) with nodular osseous metaplasia was diagnosed. The thoracic trachea was then irradiated postoperatively for definitive treatment. The cat remained asymptomatic following surgical excision and radiation therapy for 32 mo when this report was written. The purpose of this report is to describe the treatment and long-term outcome of a Maine coon diagnosed with, and treated for, tracheal BCC.

Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face

2015 ◽  
Vol 41 (7) ◽  
pp. 761-767 ◽  
Author(s):  
Aykut Bozan ◽  
Sercan Gode ◽  
Isa Kaya ◽  
Banu Yaman ◽  
Mustafa Uslu ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Surgical Margins ◽  
Positive Surgical Margins ◽  
Long Term Follow Up ◽  
The Face

Long-Term Therapy With Low-Dose Isotretinoin for Prevention of Basal Cell Carcinoma: A Multicenter Clinical Trial

1992 ◽  
Vol 84 (5) ◽  
pp. 328-332 ◽  
Author(s):  
J. A. Tangrea ◽  
B. K. Edwards ◽  
P. R. Taylor ◽  
A. M. Hartman ◽  
G. L. Peck ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Low Dose ◽  
Term Therapy ◽  
Multicenter Clinical Trial ◽  
Long Term Therapy

scholarly journals Large Basal Cell Carcinoma Defect Closure on The Lateral Cheek Using Multiple Advancement Flaps

2021 ◽  
pp. 1-7
Author(s):  
Siswanto Wahab ◽  
Khairuddin Djawad
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Histopathological Examination ◽  
Skin Flap ◽  
Reconstruction Procedure ◽  
The Face ◽  
Advancement Flaps ◽  
Substantial Morbidity

Basal cell carcinoma (BCC) is the most common type of nonmelanoma skin cancer (NMSC). It grows slowly and very rarely metastasizes but can cause substantial morbidity due to its tendency to relapse and locally invasive nature, especially when located on the face. Excision surgery is still the gold standard treatment for primary BCC and is usually followed by reconstruction procedure. Skin flap techniques vary widely, one of which is flap advancement technique. The main benefit of flap advancement technique is the ability to hide the excision line, thus resulting in an aesthetically sound outcome. We report a case of 72-year-old female with hyperpigmented plaque brownish lump on the left lateral cheek. A diagnosis of igmented basal cell carcinoma had been confirmed through histopathological examination. The patient was treated with wide excision surgery and the defect was closed by multiple advancement flaps. Follow-up after three months showed excellent cosmetic and functional outcome.

Sign in / Sign up

Export Citation Format

Share Document